Filtered By:
Source: Journal of Rehabilitation Medicine
Countries: Italy Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: An cost-utility analysis.
CONCLUSION: Despite some limitations, the higher number of quality-adjusted life years gained vs rehab and the high probability of reaching a cost-utility ratio lower than the Italian informal acceptability range (€25,000-40,000) make rehab/aboBoNT-A a cost-effective healthcare programme for treating patients with post-stroke spasticity in Italy. PMID: 31820010 [PubMed - as supplied by publisher]
Source: Journal of Rehabilitation Medicine - December 12, 2019 Category: Rehabilitation Tags: J Rehabil Med Source Type: research